Medijski sadržaj
- Tweetovi
- Tweetovi i odgovori
- Medijski sadržaj, trenutna stranica.
-
IAmBiotech: The Message We Hope President Trump Will Convey During His State of the Union Address from JimGreenwood https://buff.ly/398V1VH
#SOTU
pic.twitter.com/4DKUZC9eOJ
-
IAmBiotech: Download your copy of BIO’s first annual report on
#diversity and#inclusion in#biotechnology at https://buff.ly/2UaLj0N#rightmixmatterspic.twitter.com/Ut51a4gwKa
-
IAmBiotech: On
#WorldCancerDay
—instead of celebrating new treatments, policymakers continue to promote #drugprice controls that would harm future cures. VIDEO: how an international price index would have an “absolutely chilling” effect on investments in …https://youtu.be/TfsvHdIgyJg -
IAmBiotech: For nearly 2 decades, the BIO World Congress has been a catalyst for the growth of the biobased economy. But to better represent the influence biotech innovation has across sectors, today we are unveiling a new name: BIO IMPACT Ag & Environme…pic.twitter.com/Qp77ZiIr6j
-
IAmBiotech: Celebrating
#BlackHistoryMonth
: 10 Prominent African American #LifeScience Leaders https://buff.ly/31kPEjE#rightmixmatterspic.twitter.com/Iu9qPS8Q4u
-
IAmBiotech: Antibody Screening Technology Is Never Out of Sorts https://buff.ly/391sEZt pic.twitter.com/8Yy2HSfZEt
-
IAmBiotech:
#Biotech investor Alex Karnal warns that realDonaldTrump’s plan to import foreign price controls would have an “absolutely chilling” effect on investments in transformational, life-saving therapies. https://buff.ly/2uYOgXJ pic.twitter.com/RRlTT4In0v
-
NatureBiotech: A computationally designed chimeric antigen receptor provides a small-molecule safety switch for T-cell therapy https://go.nature.com/2u6baMX pic.twitter.com/6F17bQgfyT
-
NatureBiotech: Interleukin-23 engineering improves CAR T cell function in solid tumors https://go.nature.com/395591Q pic.twitter.com/DpB7OUV9XE
-
IAmBiotech: Download your copy of BIO’s first annual report on
#diversity and#inclusion in#biotechnology at https://buff.ly/3aT7ejb#rightmixmatterspic.twitter.com/stW6kw6uzJ
-
IAmBiotech: How does
#diversity and#incluson look in#biotech? More work is needed, says our new report. Read all the findings: https://buff.ly/2RJvrRk pic.twitter.com/x4zEteFnAz
-
IAmBiotech: Download your copy of BIO’s first annual report on
#diversity and#inclusion in#biotechnology at https://buff.ly/2RF1TnM#rightmixmatterspic.twitter.com/s2BXfnsx4V
-
IAmBiotech: What do you enjoy eating during the
#BigGame? if it involves cheese, nuts, beer or a few other popular, delicious treats, then you enjoy GMOs (and that's good!). https://buff.ly/3aTlPel pic.twitter.com/PPtkYBQwgE
-
IAmBiotech: NIH Grants $4.8 Million to Gladstone Institutes to Study ApoE4 in
#Alzheimer's https://buff.ly/31ebOnp pic.twitter.com/RCECMICcev
-
IAmBiotech: Food prep for the
#BigGame? You might owe a thanks to#agtech and#nature, both of which have helped us enjoy favorite foods: https://buff.ly/3aX3Xzc pic.twitter.com/Z2FrwBBCtg
-
NatureBiotech: RT nresearchnews: Join experts in bioengineering exploring technologies with the potential to transform biomedical discovery and new medical solutions at our upcoming NatureConf in Munich, Germany. http://go.nature.com/35eetz7 pic.twitter.com/a1py3IETtO
-
IAmBiotech: How can we prevent, prepare for, and respond to outbreaks of infectious diseases such as
#coronavirus,#Ebola,#Zika, avian influenza (HPAI) and#MERS? Biotech and#OneHealth has answers: https://buff.ly/2S69hrs pic.twitter.com/8EyoiWy2no
-
IAmBiotech: Sign up for the BIO Boardlist to support our mission of promoting workforce development,
#diversity, and#inclusion at https://buff.ly/2S7rchc#rightmixmatterspic.twitter.com/iGJoAt0WHu
-
IAmBiotech: New drug candidate created by AI in ‘world first’ https://buff.ly/2GK0OVn
#AI#biotech#innovation#drugdiscoverypic.twitter.com/H2hClEr780
-
IAmBiotech: BIO is helping leaders fulfill that commitment by providing resources to help build a more inclusive and diverse workforce. Learn more at https://buff.ly/2S3JkIT
#rightmixmatterspic.twitter.com/6M7dHHLKNb
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.